中文
| Catalogue |
|
|
| Recommend Products |
ProBioGen AG
Germany, Manufacturer, Hits: 619, Updated:10/6/2022
Herbert-Bayer-Stra?e 8 13086 Berlin, Germany |
Company Profile
-
ProBioGen is a Berlin-based biotech company, so-called Contract Development and Manufacturing Organization (CDMO) and technology provider that operates globally. It specializes in developing and manufacturing biopharmaceutical active ingredients and vaccines, applying proprietary technologies to improve product quality and features. It started in 1994 as a spin-off of Charité, widely recognized as the best hospital in Germany. Twenty-eight years later, nearly 300 employees work at ProBioGen's three locations in Berlin. Every day, they contribute to the creation of new therapies in medicine and groundbreaking innovations worldwide through their creative and meticulous work. ProBioGen's growth strategy is driven by the expansion of the service value chain through organic growth and potential acquisition. Diversification is a complement driver, while the focus is strict on enabling the development of biopharmaceuticals for tomorrow.
For more information about ProBioGen, follow us on LinkedIn.
Company News
- ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic ... 4/2/2024
- ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic ... 3/28/2024
- ProBioGen Partners with MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylate... 3/14/2024
- ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production 1/23/2023
- ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology 1/11/2023
- ProBioGen Celebrates "A New Dawn in Biotechnology" 10/6/2022